Você esta aqui:Home > Cannabinoids (antigo) > In humans, ajulemic acid has a more favorable side-effect profile than THC for the treatment of chronic neuropathic pain

Cannabinoids 2007;2(1):1-2 (21 January 2007)

Comment

In humans, ajulemic acid has a more favorable side-effect profile than THC for the treatment of chronic neuropathic pain

Sumner H. Burstein

Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01655, USA, sumner.burstein@umassmed.edu

This is a comment on a report by Vann et al. (2006) on the pharmacological effects of ajulemic acid compared to CB1 receptor agonists. Their data, which were obtained using animal models, suggested an unfavorable therapeutic index as an analgesic. However, the available clinical data do not support such conclusions and indicate a deficiency in some of their models.

PDF do texto completo ]

Eventos Online 2020

Todas as informações sobre os Eventos IACM Online, incluindo vídeos gratuitos dos webinars com legendas em português, podem ser encontradas aqui.

Conferência 2022

A 12ª Conferência IACM sobre Canabinóides em Medicina será adiada para o Outono de 2022 e será realizada como um evento híbrido na Suíça e online.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.